TMCnet News
Research and Markets: Global Neuroendocrine Cancer Clinical Trials Review, H1, 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/63z4r9/neuroendocrine) has announced the addition of the "Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014" report to their offering. Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014" provides data on the Neuroendocrine Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuroendocrine Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, pominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuroendocrine Cancer. Scope
Clinical Trial Overview of Top Companies/Institutions
Visit http://www.researchandmarkets.com/research/63z4r9/neuroendocrine
|